These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33199641)

  • 1. Mutation bias within oncogene families is related to proliferation-specific codon usage.
    Benisty H; Weber M; Hernandez-Alias X; Schaefer MH; Serrano L
    Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30848-30856. PubMed ID: 33199641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codon usage regulates human KRAS expression at both transcriptional and translational levels.
    Fu J; Dang Y; Counter C; Liu Y
    J Biol Chem; 2018 Nov; 293(46):17929-17940. PubMed ID: 30275015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Redundant and Overlapping Oncogenic Readouts of Non-Canonical and Novel Colorectal Cancer KRAS and NRAS Mutants.
    Alcantara KMM; Malapit JRP; Yu RTD; Garrido JAMG; Rigor JPT; Angeles AKJ; Cutiongco-de la Paz EM; Garcia RL
    Cells; 2019 Dec; 8(12):. PubMed ID: 31816869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-ras activation and expression in transformed mouse lung cell lines.
    Pan YH; Nuzum EO; Hanson LA; Beer DG
    Mol Carcinog; 1990; 3(5):279-86. PubMed ID: 2244960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare codons regulate KRas oncogenesis.
    Lampson BL; Pershing NL; Prinz JA; Lacsina JR; Marzluff WF; Nicchitta CV; MacAlpine DM; Counter CM
    Curr Biol; 2013 Jan; 23(1):70-5. PubMed ID: 23246410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
    Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
    Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.
    Schulten HJ; Salama S; Al-Ahmadi A; Al-Mansouri Z; Mirza Z; Al-Ghamdi K; Al-Hamour OA; Huwait E; Gari M; Al-Qahtani MH; Al-Maghrabi J
    Anticancer Res; 2013 Nov; 33(11):4779-84. PubMed ID: 24222113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ras gene family and human carcinogenesis.
    Bos JL
    Mutat Res; 1988 May; 195(3):255-71. PubMed ID: 3283542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kirsten Ras* oncogene: significance of its discovery in human cancer research.
    Tsuchida N; Murugan AK; Grieco M
    Oncotarget; 2016 Jul; 7(29):46717-46733. PubMed ID: 27102293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic activating mutations are associated with local copy gain.
    Modrek B; Ge L; Pandita A; Lin E; Mohan S; Yue P; Guerrero S; Lin WM; Pham T; Modrusan Z; Seshagiri S; Stern HM; Waring P; Garraway LA; Chant J; Stokoe D; Cavet G
    Mol Cancer Res; 2009 Aug; 7(8):1244-52. PubMed ID: 19671679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships among
    Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
    World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Characterization of KRAS, BRAF, and EGFR Genes in Cases with Prostatic Adenocarcinoma; Reporting Bioinformatics Description and Recurrent Mutations.
    Salmaninejad A; Ghadami S; Dizaji MZ; Golchehre Z; Estiar MA; Zamani MR; Ebrahimzadeh-Vesal R; Nowroozi MR; Shakoori A
    Clin Lab; 2015; 61(7):749-59. PubMed ID: 26299074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
    Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
    Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model for RAS mutation patterns in cancers: finding the sweet spot.
    Li S; Balmain A; Counter CM
    Nat Rev Cancer; 2018 Dec; 18(12):767-777. PubMed ID: 30420765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status.
    Yang S; Farraye FA; Mack C; Posnik O; O'Brien MJ
    Am J Surg Pathol; 2004 Nov; 28(11):1452-9. PubMed ID: 15489648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-regulation of metastatic and transforming activity of normal and mutant ras genes.
    Egan SE; Broere JJ; Jarolim L; Wright JA; Greenberg AH
    Int J Cancer; 1989 Mar; 43(3):443-8. PubMed ID: 2784421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological properties of human c-Ha-ras1 genes mutated at codon 12.
    Seeburg PH; Colby WW; Capon DJ; Goeddel DV; Levinson AD
    Nature; 1984 Nov 1-7; 312(5989):71-5. PubMed ID: 6092966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of N-ras induced by ultraviolet irradiation in vitro.
    Van der Lubbe JL; Rosdorff HJ; Bos JL; Van der Eb AJ
    Oncogene Res; 1988; 3(1):9-20. PubMed ID: 3060800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-ras oncogene point mutations in arthritic synovium.
    Roivainen A; Jalava J; Pirilä L; Yli-Jama T; Tiusanen H; Toivanen P
    Arthritis Rheum; 1997 Sep; 40(9):1636-43. PubMed ID: 9324018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.